Chris Laing

Chris Laing is the Chief Executive Officer of ClavystBio. Chris also serves as the Vice Dean of Innovation and Entrepreneurship at Duke-NUS Medical School.

Prior moving to SIngapore, Chris oversaw the Science Center’s programs for commercialization, startup investment and business incubation. Since 2009, participants in these programs, which include QED, Phase 1 Ventures, the Digital Health Accelerator, and the Port business incubators, have collectively raised hundreds of millions in venture financing. Chris also facilitates access by program participants to Greater Philadelphia’s academic and clinical communities through the Science Center’s Scientific Advisory Committee for the Board of Directors.